학술논문

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
Document Type
Journal
Source
LANCET HIV; FEB 2024, 11 2, pe75-pe85, 11p.
Subject
Language
English
ISSN
23523018